Glenmark Pharmaceuticals Key Metrics

Trade
BSE: 532296 | NSE: GLENMARK | ISIN: INE935A01035 | Sector: Biotechnology & Drugs
1,493.45 +13.40 (0.91%)Updated : 25 Nov 2024
Ratios
Return on average equity - 5 year average1.61
Net Income/employee - trailing 12 month-6,62,822.80
Revenue/employee - most recent fiscal year77,34,881.00
Return on investment - most recent fiscal year-15.92
Return on average assets - most recent fiscal year-10.86
Receivables turnover - most recent fiscal year4.28
Return on investment - trailing 12 month-8.51
Return on average assets - trailing 12 month-5.64
Inventory turnover - most recent fiscal year1.91
Inventory turnover - trailing 12 month1.53
Revenue/employee - trailing 12 month81,71,082.00
Return on average assets - 5 year average1.02
Net Income/employee - most recent fiscal year-11,98,789.00
Return on average equity - trailing 12 month-11.46
Receivables turnover - trailing 12 month4.04
Asset turnover - most recent fiscal year0.70
Asset turnover - trailing 12 month0.70
Return on average equity - most recent fiscal year-21.93
Return on investment - 5 year average1.43
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts